Table 4.

Preoperative adverse effects by randomised treatment group

	Self-administered vaginal placebo (n = 34)	Self-administered vaginal misoprostol (n = 33)
No adverse effects, n (%)	23 (67.6)	18 (54.5)
Lower abdominal pain, n (%)	8 (23.5)	13 (39.4)
Mean level of reported preoperative pain* (SD)	1.0 (1.7)	1.5 (2.1)
Constipation, n (%)	2 (5.9)	0
Vaginal bleeding, n (%)	0	2 (6.1)
Vaginal discharge, n (%)	1 (2.9)	0

^*Measured with a visual analogue scale score, ranging from 0 (no pain) to 10 (unbearable pain).